Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced it has entered into a strategic alliance with the NYU Grossman School of Medicine’s Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. Novocure’s Tumor Treating Fields are electric fields that disrupt cancer cell division. “It is our …

Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update

Quarterly net revenues of $132.7 million, representing 44 percent growth versus the third quarter 2019 and 14 percent growth versus the second quarter 2020 Quarterly net income of $9.3 million with $0.09 in earnings per share ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended September 30, 2020, highlighting revenue …

Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update

Quarterly net revenues of $99.2 million, representing 42 percent growth versus the fourth quarter 2018 and 8 percent growth versus the third quarter 2019 Second quarter of positive net income with $0.04 in earnings per share Four phase 3 pivotal clinical trials ongoing creating the potential for substantial market expansion ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: …